Wockhardt Q3 PAT dips 29 pc

The troubled pharmaceutical company Wockhardt has posted a 29% decline in its net profit for the third quarter at Rs 304 crore, against Rs 428 crore.

The company, which see 79% of its revenue contribution from international markets, witnessed 30% revenue loss from the the US market. The import to US market was hit by USFDA import alert on its Indian plants.

Revenue has seen a decline of 14% for third quarter at Rs 1,237 crore, against Rs 1,435 crore. Its India business has posted a 6% growth.

The UK business has recorded a 10% growth while Irish market recorded a 25% growth for the quarter.

The company has increased its research spend at 7.9% to sales which is about Rs 98 crore for the quarter.

In November last year, the US Food and Drug Administration (FDA) had imposed an import alert on its manufacturing unit at Chikalthana, Aurangabad, in Maharashtra. The plant had generated sales of $283 million (Rs 1,700 crore) in financial year 2013.

In May, FDA had imposed a ban on the company’s Waluj plant after inspectors found torn data records in a waste heap and urinals that emptied into an open drain in a bathroom six metres from the entrance to a sterile manufacturing area.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • Media obsession with his layoff smacks of lack of focus

    Pretty much like his abrupt vanishing act had done 50-odd days ago, Congress vice president Rahul Gandhi’s return on Thursday from a long and myster

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

Sarthak Raychaudhuri

vice-president, HR, Asia South Whirlpool of India

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

TODAY'S COLUMNS

Varun Dutt

<b>Riskfactor</b>: Oblivious to reality

The hostile media effect, originally deemed the hostile media phenomenon, ...

Zehra Naqvi

Sensual wordplay

The student of literature looks for form and structure. The ...

Bubbles Sabharwal

The bitter cold heart of life

Life has a heart just as we do. Most times ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture